| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Koenig Sheldon L. | President and CEO, Director | C/O ESPERION THERAPEUTICS, INC., 3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR | /s/ Sheldon L. Koenig | 18 Sep 2025 | 0001766524 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ESPR | Common Stock | Sale | $79,254 | -28,427 | -1.8% | $2.79 | 1,518,831 | 17 Sep 2025 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Shares were sold to satisfy tax obligation on vested shares of restricted stock units. |
| F2 | Includes 5,770 shares recently acquired in Esperion's Employee Stock Purchase Plan. |